Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bacon Shortage? This Board Member Is Ready

Smithfield Foods, Inc. (NYSE:SFD), the largest pork processor in the world according to the company, is currently down 17% on the year, with even speculation of an impending shortage of pork products next year (as higher grain prices dissuade farmers from raising hogs and other livestock) failing to boost the stock’s price. Apparently David Nelson, a Board member at the company, believed that the stock price had fallen far enough. According to SEC filings, Nelson purchased 5,000 shares on September 28th at an average price of $19.56, bringing the total number of shares he directly owns to 35,000. He had previously bought 5,000 shares in the middle of June at an average price of $19.99, so he has recently put about $200,000 into the company at about the current stock price (about $20 even at the time of this writing). Studies on insider trading show that statistically they tend to be bullish signs, so we track stocks seeing insider buying activity as ideas to be investigated further.


Hedge funds, however, generally avoided Smithfield Foods, Inc. during the second quarter (at least compared to other stocks). The two largest hedge fund positions in the stock at the end of June according to our database of 13F filings belonged to Citadel Investment Group and Renaissance Technologies, at about $20 million each. Citadel, managed by billionaire Ken Griffin, increased its stake to a total of 1.1 million shares (find other stocks Citadel Investment Group owns). Renaissance, whose success since inception has made founder Jim Simons a billionaire, initiated a position of about 830,000 shares during the second quarter (see more stocks that Renaissance liked during the second quarter).

Revenue in Smithfield’s first fiscal quarter, which ended in July, was about flat compared to the same period in 2011. Due to rising costs, net income fell from $82 million to $62 million; the company’s share count was down slightly as well, but earnings per share still dropped 18%. The drop in the share price and the recent trends in the business have left Smithfield Foods, Inc. trading at 9 times trailing earnings. Wall Street analysts expect the current year’s earnings per share to come in 29% lower than in the last year; this would require the company to do even worse than it did in the first quarter. Smithfield also plans to buy back stock, initiating a new repurchase program this past June, making that 29% target- which would leave the current price at 11 times current year earnings, a reasonable price- seemingly easy to beat.

The closest peers for Smithfield are meat products-focused Hormel Foods Corporation (NYSE:HRL) and Tyson Foods, Inc. (NYSE:TSN), processed foods provider ConAgra Foods, Inc. (NYSE:CAG), and chicken products company Pilgrim’s Pride Corporation (NYSE:PPC). ConAgra Foods and Hormel showed moderate increases in revenue last quarter compared to the same period a year ago, and both companies converted this rise into an increase in earnings as well. They trade at a substantial premium to Smithfield: Hormel, the cheaper one, trades at 16 times trailing earnings. Their better recent performance and good dividend yields (ConAgra’s is 3.6%) are attractive, possibly even enough to overcome their higher pricing. Pilgrim’s Pride is unprofitable on a trailing basis, due to a poor second half of 2011, and trades at 14 times forward earnings estimates. We like that it seems to be rebounding, but doesn’t seem to be as good a buy. Tyson is the closest to joining Smithfield as a potential value stock, at trailing and forward P/Es of 12 and 11, respectively. However, a sharp rise in interest expenses with little accompanying change in revenue drove its earnings down in its most recent quarter versus last year.

We like that Smithfield is seeing insider buying, and even with what seem like fairly pessimistic analyst expectations the stock seems priced about fairly compared to better-performing meat products companies with higher earnings multiples. It could be a good stock to watch.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!